SecBot SecBot
SECBOTREPLAY Home › Report › CRL

CRL · Invesco 13G/A 3.9% stake

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · SC 13G/A filed Nov 10, 2026 at 15:03 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 10, 2026 at 15:03 ET

Invesco Ltd. filed an amended Schedule 13G for Charles River Laboratories, reporting beneficial ownership of 1,852,539 shares (3.9% of common stock) as of September 30, 2026. This is a routine passive stake update filed six days after the company's Q3 2026 earnings beat. The stake decreased from the prior filing (Invesco's initial 13G on August 13, 2026 did not disclose a percentage, but the current 3.9% is below the 5% threshold and represents a reduction from the prior filing's undisclosed level).

  • Invesco Ltd. reported beneficial ownership of 1,852,539 shares of Charles River Laboratories common stock as of September 30, 2026.
  • The stake represents 3.9% of shares outstanding, below the 5% threshold.
  • This is an amendment to a Schedule 13G, indicating passive investment intent.
  • The filing was made on November 10, 2026, six days after the company's Q3 2026 earnings beat.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access